# Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Study · id `cardio:ct-nct01443104` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01443104](<https://clinicaltrials.gov/study/NCT01443104>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01443104

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2119 participants.

## Technical summary

Registry record NCT01443104. Randomized; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2119 participants (enrolled count; ClinicalTrials.gov record NCT01443104, source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)
- Started: 2012-02 (actual) (ClinicalTrials.gov record NCT01443104, source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)
- Primary completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01443104, source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)
- Completion: 2018-06 (actual) (ClinicalTrials.gov record NCT01443104, source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT01443104, source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01443104-2018-10-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
- Condition: Coronary Artery Disease
- Condition: Angina Pectoris
- Condition: Myocardial Infarction
- Intervention (Device): Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
- Intervention (Device): Everolimus-eluting stent with a durable polymer
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER
- Collaborator: Biotronik AG
- Collaborator class: INDUSTRY
- Collaborator: University of Bern
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)
- Registry lists this organization as a collaborator: Biotronik AG (`cardio:org-biotronik-ag`)
- Registry lists this organization as a collaborator: University of Bern (`cardio:org-university-of-bern`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial (`cardio:pubmed-25189359`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial (`cardio:pubmed-26979080`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial (`cardio:pubmed-26043895`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction (`cardio:pubmed-26690319`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial (`cardio:pubmed-30170848`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial (`cardio:pubmed-31525083`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents (`cardio:pubmed-31696762`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial (`cardio:pubmed-33653633`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 25319ae6ac114863e99a4759860f15aa967cf1c99ff846d64157bf008ffcf47a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
